
    
      This clinical trial follows a descriptive study design collecting data to measure and monitor
      variables related to the standard of care in providing speech language pathology augmentative
      and alternative communication clinical (AAC) assessment and treatment. The study tracks
      participants through the AAC, speech generating device trial and AAC-BCI trial processes. In
      addition this study measures and monitors the communication performance of individuals using
      the AAC-BCI and any other AAC strategies for treatment in the home. Data on communication
      performance, user satisfaction, and perceptions of communication effectiveness are gathered
      over monthly visits along with the satisfaction and perceptions of communication
      effectiveness by the family support persons.
    
  